Liesbeth Bergman
- Oncology top 10%
- Genetics top 10%
- Cancer Research top 10%
- Obstetrics and Gynecology top 5%
- Epidemiology
- Co-authors
- Flora E. van LeeuwenM.P.W. GalleeHarry HollemaJ. BenraadtM. LimburgJan van der MeulenJ. Dik F. HabbemaJ.A. van Dongen
- Topics
- Estrogen and related hormone effects (5 papers)Breast Cancer Treatment Studies (4 papers)Endometrial and Cervical Cancer Treatments (4 papers)
- Journals
- The LancetCancerStroke
- Partner nations
- NetherlandsUnited States
In The Last Decade
Liesbeth Bergman
9 papers receiving 766 citations
Peers
Comparison fields: 5 of 74
- Oncology 311
- Genetics 302
- Cancer Research 239
- Obstetrics and Gynecology 195
- Epidemiology 142
Countries citing papers authored by Liesbeth Bergman
This map shows the geographic impact of Liesbeth Bergman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liesbeth Bergman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liesbeth Bergman more than expected).
Fields of papers citing papers by Liesbeth Bergman
This network shows the impact of papers produced by Liesbeth Bergman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liesbeth Bergman. The network helps show where Liesbeth Bergman may publish in the future.
Co-authorship network of co-authors of Liesbeth Bergman
This figure shows the co-authorship network connecting the top 25 collaborators of Liesbeth Bergman. A scholar is included among the top collaborators of Liesbeth Bergman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liesbeth Bergman. Liesbeth Bergman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Tamoxifen and risk of endometrial cancer - Reply | 1 |
| 2 | 6 | |
| 3 | 388 | |
| 4 | 4 | |
| 5 | 0 | |
| 6 | 42 | |
| 7 | 126 | |
| 8 | 70 | |
| 9 | 73 | |
| 10 | 92 |
About Liesbeth Bergman
Liesbeth Bergman is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Cancer Research, having authored 10 papers that have together received 802 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (5 papers), Breast Cancer Treatment Studies (4 papers) and Endometrial and Cervical Cancer Treatments (4 papers). The work is most often cited by research in Obstetrics and Gynecology (195 citations), Cancer Research (239 citations) and Reproductive Medicine (111 citations). Liesbeth Bergman has collaborated with scholars based in Netherlands and United States. Frequent co-authors include Flora E. van Leeuwen, M.P.W. Gallee, Harry Hollema, J. Benraadt, M. Limburg, Jan van der Meulen, J. Dik F. Habbema, J.A. van Dongen, Frits S.A.M. van Dam and Hans Peterse. Their work appears in journals such as The Lancet, Cancer and Stroke.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.